Integrating Methylation Signature Modifications and Subtype Classification into a Prognostic Risk Model for Survival Prognosis and Predicting Immunotherapy Response in Colorectal Cancer.
This study shows that the integrated analysis of multiple RNA methylation modifications provides a more comprehensive view of epitranscriptomic heterogeneity in CRC than single-modification approaches and suggests that multi-modification-based models may improve prognostic accuracy and help identify CRC patients who ma...